Armstrong, K <br/><br/>
Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.  [electronic resource] 

 -  Obstetrics and gynecology  Dec 2001 
 - 996-1003 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0029-7844 
<br/><br/><label>Standard No.: </label>10.1016/s0029-7844(01)01624-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Coronary Disease--prevention & control<br/>Cost-Benefit Analysis<br/>Decision Support Techniques<br/>Estrogen Antagonists--economics<br/>Female<br/>Health Promotion--economics<br/>Hormone Replacement Therapy--economics<br/>Humans<br/>Life Expectancy<br/>Markov Chains<br/>Middle Aged<br/>Postmenopause<br/>Quality-Adjusted Life Years<br/>Raloxifene Hydrochloride--economics<br/>United States